文章摘要
不同剂量前列腺素E1雾化吸入对单肺通气时肺内分流和氧合的影响
Effects of different doses of aerosolized prostaglandin E1 inhalation on pulmonary shunt and oxygenation during one-lung ventilation
  
DOI:10.12089/jca.2023.11.002
中文关键词: 单肺通气  前列腺素E1  低氧血症  食管癌  肺损伤
英文关键词: One-lung ventilation  Prostaglandin E1  Hypoxia  Esophageal neoplasms  Lung injury
基金项目:江苏省肿瘤医院优才项目(YC201805)
作者单位E-mail
李彭欣 221004,徐州医科大学麻醉学院  
仇蕾 221004,徐州医科大学麻醉学院  
王丽君 南京医科大学附属肿瘤医院麻醉科  
李彭依 南京医科大学附属肿瘤医院麻醉科  
顾连兵 221004,徐州医科大学麻醉学院 13951947684@163.com 
摘要点击次数: 927
全文下载次数: 243
中文摘要:
      
目的 探讨在FiO240%下单肺通气(OLV)前通气侧肺雾化吸入不同剂量前列腺素E1(PGE1)对肺内分流和氧合的影响。
方法 选择行食管癌根治术患者156例,男121例,女35例,年龄18~64岁,BMI 18~30 kg/m2,ASA Ⅱ或Ⅲ级。采用随机数字表法将患者分为四组:PGE1 0.3 μg/kg组(H组,n=39)、PGE1 0.2 μg/kg组(M组,n=38)、PGE1 0.1 μg/kg组(L组,n=39)和生理盐水对照组(C组,n=40)。四组OLV前分别于右肺超声雾化吸入PGE1 0.1、0.2、0.3 μg/kg或生理盐水,雾化时间10 min。分别在麻醉诱导前(T0)、雾化前(T1)、OLV 10 min(T2)、OLV 15 min(T3)、OLV 30 min(T4)、OLV 60 min(T5)和OLV 120 min(T6)采集桡动脉和颈内静脉血行血气分析,记录HR、MAP、PaO2、氧合指数(OI)、肺内分流率(Qs/Qt)、PaCO2和气道峰压(Ppeak)。记录术中低氧血症、术中低血压、术后第2天临床肺部感染评分(CPIS)和7 d内术后肺部并发症(PPCs)发生情况。
结果 与C组比较,L组、M组和H组术中低氧血症发生率明显降低(P<0.05),T2、T3时H组MAP明显降低(P<0.05),T2—T4时L组、M组和H组Qs/Qt明显降低、PaO2和OI明显升高(P<0.05),H组术后第2天CPIS明显降低(P<0.05)。与L组比较,T2—T4时H组Qs/Qt明显降低(P<0.05),T3、T4时H组PaO2和OI明显升高(P<0.05)。四组低血压发生率、不同时点HR、PaCO2、Ppeak和术后7 d内PPCs发生率差异无统计学意义。
结论 在FiO2 40%下,OLV前PGE1 0.1、0.2和0.3 μg/kg雾化吸入均可降低肺内分流、改善氧合,降低低氧血症发生率,但对PPCs无明显影响。PGE1 0.3 μg/kg 改善氧合效果最好,且能降低术后第2天CPIS,但需密切关注循环波动。
英文摘要:
      
Objective To investigate the effects of aerosolized inhalation of different doses of prostaglandin E1(PGE1) on pulmonary shunt and oxygenation during one-lung ventilation (OLV) when the fraction of inspiration O2 was 40%.
Methods A total of 156 patients undergoing radical operation of esophageal cancer, 121 males and 35 females, aged 18-64 years and BMI 18-30 kg/m2, ASA physical status Ⅱ or Ⅲ were included in the study. The patients were randomly assigned into 4 groups using a random number table: PGE1 0.1 μg/kg group (group L, n = 39), PGE1 0.2 μg/kg group (group M, n = 38), PGE1 0.3 μg/kg group (group H, n = 39), and a saline control group (group C, n = 40). Patients received different therapy before OLV, namely inhaling either PGE1 0.1, 0.2, 0.3 μg/kg, and saline into right lung for a duration of 10 minutes. Venous blood and arterial blood were drawn from right internal jugular vein catheter and radial artery catheter for blood gas analysis at pre-anesthesia (T0), pre-nebulization (T1), OLV 10 minutes (T2), OLV 15 minutes (T3), OLV 30 minutes (T4), OLV 60 minutes (T5), and OLV 120 minutes (T6). HR, MAP, PaO2, oxygenation index (OI), pulmonary shunt fraction (Qs/Qt), PaCO2, and peak airway pressure (Ppeak) were also recorded at above time points. Intraoperative hypoxemia, intraoperative hypotension, clinical pulmonary infection score (CPIS) on the second postoperative day and postoperative pulmonary complications (PPCs) within 7 days were recorded.
Results Compared with group C, groups L, M, and H showed a lower incidence of hypoxemia (P < 0.05), group H demonstrated lower MAP at T2 and T3 (P < 0.05), groups L, M, and H displayed lower Qs/Qt and higher PaO2 and OI at T2-T4(P < 0.05), group H had a lower CPIS on the second postoperative day (P < 0.05). Compared with group L, group H exhibited lower Qs/Qt at T2- T4, and higher PaO2 and OI at T3 and T4. There were no significant differences in the incidence of hypotension, HR, PaCO2, Ppeak, and the occurrence of PPCs within 7 days among the four groups.
Conclusion Nebulized inhalation of PGE1 0.1, 0.2 and 0.3 μg/kg under FiO2 40% before OLV can effectively reduce Qs/Qt, improve oxygenation and decrease the incidence of hypoxemia. However, it has no significant impact on PPCs. PGE1 0.3 μg/kg exhibits the best improvement in oxygenation and can also reduce CPIS on the second postoperative day, close monitoring of circulatory fluctuations is still required.
查看全文   查看/发表评论  下载PDF阅读器
关闭